Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 299-309

  Serhan, Charles N ^a   Takano, Tomoko ^a,b   Gronert, Karsten ^a   Chiang, Nan ^a   Clish, Clary B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Anti inflammatory mediators; Eicosanoids; Lipid mediators; Receptors

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; HYDROXY FATTY ACID; ICOSANOID; LIPOXIN;

ANIMAL CELL; ATHEROSCLEROSIS; CELL INTERACTION; CELL TRANSPORT; CONFERENCE PAPER; EPITHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS;

ANIMALIA;

EID: 0032948217     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.052     Document Type: Conference Paper

References (55)

1. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci 1989; 77:195-203.
2. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 1993; 92:75-82.
3. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 1996; 156:2264-72.
4. 4 receptor interaction. Biochemistry 1995; 34:16678-86.
5. 4 receptor. J Exp Med 1994; 180:253-60.
6. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45:361-78.
7. 4. Adv Exp Med Biol 1991; 314:185-92.
8. Babior BM. Activation of the respiratory burst oxidase. Environ Health Perspect 1994; 102 (Suppl. 10):53-6.
9. Serhan CN, Haeggström JZ, Leslie CC. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10:1147-58.
10. Serhan CN. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 1997; 53:107-37.
11. Nassar GM, Morrow JD, Roberts LJ, II, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem 1994; 269:27631-4.
12. Clària J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995; 92:9475-9.
13. Clària J, Lee MH, Serhan CN. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 1996; 2:583-96.
14. Kim SJ, Tominaga T. Formation of lipoxins by the brain. Ann New York Acad Sci 1989; 559:461-4.
15. Mayadas TN, Mendrick DL, Brady HR, Tang T, Papayianni A, Assmann KJM, et al. Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int 1996; 49:1342-9.
16. 4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int 1995; 47:1295-302.
17. 4. J Pharmacol Exp Ther 1996; 278:950-6.
18. 4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992; 145:1281-4.
19. 4 with human neutrophils. J Biol Chem 1992; 267:16168-76.
20. 4 inhibits phosphoinositide hydrolysis in human neutrophils. Biochem Biophys Res Commun 1990; 167:1022-9.
21. 4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc Natl Acad Sci USA 1989; 86:3438-42.
22. 4 receptors in HL-60 cells. Blood 1993; 81:3395-403.
23. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 1997; 185:1693-704.
24. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 1995; 34:14609-15.
25. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA. Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994; 63:101-32.
26. Perez HD, Holmes R, Kelly E, McClary J, Andrews WH. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene (Amst) 1992; 118:303-4.
27. 4 receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release. J Exp Med 1998; 187:1285-94.
28. 4 analogs with increased biologic activity. FASEB J 1998; 12:487-94.
29. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 1996; 183:137-46.
30. 4 receptor. J Biol Chem 1997; 272:6972-8.
31. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-9.
32. Toh H, Ichikawa A, Narumiya S. Molecular evolution of receptors for eicosanoids. FEBS Lett 1995; 361:17-21.
33. 4 that mediates chemotaxis. Nature 1997; 387:620-4.
34. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272 (5263):872-7.
35. Oravecz T, Pall M, Norcross MA. β-Chemokine inhibition of monocytotropic HIV-1 infection: interference with a post-binding fusion step. J Immunol 1996; 157:1329-32.
36. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176:1703-18.
37. 4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc Natl Acad Sci USA 1998; 95:9530-4.
38. Ekerdt R, Müller B. Role of prostanoids in the inflammatory reaction and their therapeutic potential in the skin. Arch Dermatol Res 1992; 284:S18-21.
39. 4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci USA 1997; 94:9967-72.
40. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 1994; 49:230-4.
41. Stenke L, Mansour M, Edenius C, Reizenstein P, Lindgren JA. Formation and proliferative effects of lipoxins in human bone marrow. Biochem Biophys Res Commun 1991; 180:255-61.
42. 4 and decreased lipoxin formation in chronic myeloid leukemia. Adv Prostaglandin Thromboxane Leukot Res 1990; 216:883-6.
43. Stenke L, Edenius C, Samuelsson J, Lindgren JÅ. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood 1991; 78:2989-95.
44. 4 on signal transduction events in Friend erythroleukemia cells. Proc Soc Exp Biol Med 1992; 201:169-73.
45. Serhan CN, Hirsch U, Palmblad J, Samuelsson B. Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett 1987; 217:242-6.
46. 4. Impact of aspirin therapy. Circulation 1992; 86:56-63.
47. Papayianni A, Takata S, Serhan CN, Brady HR. Counter-regulatory actions of leukotrienes (LT) and lipoxins (LX) on P-selectin expression on human endothelial cells and neutrophil-endothelial cell adhesion [abstract 126P]. J Am Soc Nephrol 1993; 4:627.
48. Badr KF, Serhan CN, Nicolaou KC, Samuelsson B. The action of lipoxin-A on glomerular microcirculatory dynamics in the rat [published erratum appears in Biochem Biophys Res Commun 1987 Sep 30;147(3):1300]. Biochem Biophys Res Commun 1987; 145:408-14.
49. 4 stable analogues. J Clin Invest 1998; 101:819-26.
50. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990; 141:1453-8.
51. Chavis C, Chanez P, Vachier I, Bousquet J, Michel FB, Godard P. 5,15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem Biophys Res Commun 1995; 207:273-9.
52. Chavis C, Vachier I, Chanez P, Bousquet J, Godard P. 5(S),15(S)-Dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J Exp Med 1996; 183:1633-43.
53. Edenius C, Kumlin M, Björk T, Anggard A, Lindgren JA. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 1990; 272:25-8.
54. 4-ELISA. Lipids 1993; 28:1047-53.
55. Thomas E, Leroux JL, Blotman F, Chavis C. Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis, Inflamm Res 1995; 44:121-4.